Hyoscine butylbromide – a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures

References

• Lloret J, Muñoz J, Monmany J, et al. Treatment of renal colic with dipyrone. Curr Ther Res 1987;42:1119-28
   Web of Science ®Google Scholar
• Stankov G, Schmieder G, Zerle G, et al. Double-blind study with dipyrone versus tramadol and butylscopolamine in acute renal colic pain. World J Urol 1994;12:155-61
   PubMed Web of Science ®Google Scholar
• Iguchi M, Katoh Y, Koike H, et al. Randomized trial of trigger point injection for renal colic. Int J Urol 2002;9:475-9
   PubMed Web of Science ®Google Scholar
• Bortolotti M, Trisolino G, Barbara L. Nifedipine in biliary and renal colic. JAMA 1987;258:3516
   PubMed Web of Science ®Google Scholar
• Heron CW, Lynn AH, Marshall JH, et al. A comparison of paralysing agents in double-contrast barium meal examinations. Clin Radiol 1985;36:391-3
   PubMed Web of Science ®Google Scholar
• Asao T, Kuwano H, Ide M, et al. Spasmolytic effect of peppermint oil in barium during double-contrast barium enema compared with Buscopan. Clin Radiol 2003;58:301-5
   PubMed Web of Science ®Google Scholar
• Halligan MS, Jobling JC, Bartram CI. Benefit of intravenous muscle relaxants during barium follow through. Clin Radiol 1994;49:179-82
   PubMed Web of Science ®Google Scholar
• Baracho HM, Kamat JR, Kunkalekar K, et al. Hyoscine-N-butylbromide (Buscopan) in acceleration of labour. J Obstet Gynaecol India 1984;24:509-12
   Google Scholar
• Tewari K, Jabeen R, Sabzposh NA, et al. Comparison of hyoscine butyl bromide and valethamate bromide in shortening the duration of labour. Ind Med Gaz 2003;137:15-9
   Google Scholar
• Samal S, Gupta U, Wable M. Buscopan (hyoscine-N-butylbromide) in acceleration of labour. Ind Med Gaz 1998;8-10
   Google Scholar
• Bhattacharaya P, Joshi SG. Acceleration of labour intramuscular ‘Buscopan’ injection. J Obstet Gynaecol India 1985;35:1014-7
   Google Scholar
• Guerresi E, Gori G, Beccari A, et al. Influence of spasmolytic treatment and amniotomy on delivery times: a factorial clinical trial. Clin Ther 1981;3:382-8
   PubMed Web of Science ®Google Scholar
• Ripamonti C, Mercadante S, Groff L, et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000;19:23-34
   PubMed Web of Science ®Google Scholar
• Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007;67:1343-57
   PubMed Web of Science ®Google Scholar
• Data on file, Boehringer Ingelheim GmbH
   Google Scholar
• Butler HE, Moody HR. Hyoscine-N-butylbromide by intravenous infusion. Med J Aust 1987;147:315-6
   PubMed Web of Science ®Google Scholar
• Adib NH. Epidural scopolamine derivative injection in patients with chronic pain. Pain 1990;41(Suppl 1):S98 (Abstract 190)
   Google Scholar
• Grainger SL, Smith SE. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers. Br J Clin Pharmacol 1983;16:623-6
   PubMed Web of Science ®Google Scholar
• Chaikomin R, Wu KL, Doran S, et al. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release. Am J Physiol Gastrointest Liver Physiol 2007;292:G1099-G1104
   PubMed Web of Science ®Google Scholar
• Brandstätter G, Schinzel S, Wurzer H. Influence of spasmolytic analgesics on motility of sphincter of Oddi. Dig Dis Sci 1996;41:1814-8
   PubMed Web of Science ®Google Scholar
• Katoh K, Nomura M, Iga A, et al. Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability. J Gastroenterol 2003;38:629-35
   PubMed Web of Science ®Google Scholar
• Matzkies F, Mürtz G, Giannetti B, et al. Ultrasound studies of the effect of trospium chloride on gall-bladder kinetics. Arzneimittelforschung 1992;42:1456-8
   PubMed Web of Science ®Google Scholar
• Wagner T, Botzler R, Ritter U. Ultrasound measurement of the effect of hyoscine-N-butylbromide on cholecystokinin-induced gallbladder motility. Z Gastroenterol 1984;22:305-10
   PubMed Web of Science ®Google Scholar
• Bauer R, Wick H. Cholinergic contractions of dog urinary bladder by electrical stimulation of the pelvic and ligamenta lateralia nerves and the effects exerted on them by atropine and scopolamine butyl bromide. Arzneimittelforschung 1976;26:1359-61
   PubMed Web of Science ®Google Scholar
• Bauer R, Wick H. Comparative spasmolytic potencies of atropine sulphate and N-butyl hyoscine bromide following intravenous injection, injection into a mesenteric vein, and intraduodenal instillation. J Pharm Pharmacol 1969;21:706-7
   PubMed Web of Science ®Google Scholar
• Del Soldato P, Maggi CA, Meli A. The anesthetized guinea pig as a versatile pharmacological test object. J Pharmacol Methods 1981;5:279-85
   PubMedGoogle Scholar
• Sagrada A, Schiavone A, Cefalá A, et al. N-butyl hyoscine exerts local spasmolytic effect in the small and large bowel of the conscious dog. Arch Int Pharmacodyn Ther 1987;287:237-47
   PubMedGoogle Scholar
• Miura T, Harasawa S, Kikuchi K, et al. Endoscopic manometry of the sphincter of Oddi in dogs. Pharmacological effects of anticholinergic and selective antimuscarinic agents. Tokai J Exp Clin Med 1987;12:109-15
   PubMedGoogle Scholar
• Odes HS, Helman CA, Barbezat GO, et al. The effect of hyoscine-N-butylbromide on exocrine pancreatic secretion. S Afr Med J 1977;52:17-9
   PubMed Web of Science ®Google Scholar
• Saunders JH, Masoero G, Wormsley KG. Effect of diazepam and hyoscine butylbromide on response to secretin and cholecystokinin-pancreozymin in man. Gut 1976;17:351-3
   PubMed Web of Science ®Google Scholar
• Salomone T, Marlettini MG, Tomassetti P, et al. Effects of sympathomimetic isometheptene and anticholinergic hyoscine-N-butylbromide on glucose and insulin response to oral glucose load. Curr Ther Res Clin Exp 1985;37:695-700
   Web of Science ®Google Scholar
• Herxheimer A, de Groot AC. Some effects of injected hyoscine butylbromide: a versatile class experiment in human pharmacology. Br J Clin Pharmacol 1977;4:337-42
   PubMed Web of Science ®Google Scholar
• Danjou P, Molinier P, Berlin I, et al. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects. Br J Clin Pharmacol 1992;34:328-31
   PubMed Web of Science ®Google Scholar
• Litta-Modignani R, Mazzolari M, Barantani E, et al. Relative potency of the atropine-like effects of a new parasympatholytic drug, scopolamine-N-(cyclopropyl methyl) bromide and those of hyoscine-N-butyl bromide. Curr Med Res Opin 1978;5:333-40
   Web of Science ®Google Scholar
• Niemann H, Jakob G. Oesophageal manometric findings in human subjects after intravenous administration of a new anticholinergic agent (HSp 2986), atropine, and scopolamine butyl bromide. Arzneimittelforschung 1971;21:1220-1
   PubMedGoogle Scholar
• Hüpscher DN, Dommerholt O. Action and side effects of small doses of Buscopan in gastroduodenal radiography: a prospective study in 300 patients. Diagn Imaging Clin Med 1984;53:77-86
   PubMedGoogle Scholar
• Herxheimer A, Haefeli L. Human pharmacology of hyoscine butylbromide. Lancet 1966;2:418-21
   Web of Science ®Google Scholar
• Holdgate A, Oh CM. Is there a role for antimuscarinics in renal colic? A randomized controlled trial. J Urol 2005;174:572-5
   PubMed Web of Science ®Google Scholar
• Hofstetter AG, Kriegmair M. Treatment of ureteral colic with glycerol trinitrate. Fortschr Med 1993;111:286-8
   PubMedGoogle Scholar
• Mortelmans LJ, Desruelles D, Baert JA, et al. Use of tramadol drip in controlling renal colic pain. J Endourol 2006;20:1010-5
   PubMed Web of Science ®Google Scholar
• Grossi E, Broggini M, Quaranta M, et al. Different pharmacological approaches to the treatment of acute biliary colic. Curr Ther Res 1986;40:876-82
   Web of Science ®Google Scholar
• Herbst A, Gabor M, Freese D. Vergleich zweier Spasmolytika bei der Gallenkolik. Med Welt 1990;41:1056-9
   Google Scholar
• Kumar A, Deed JS, Bhasin B, et al. Comparison of the effect of diclofenac with hyoscine-N-butylbromide in the symptomatic treatment of acute biliary colic. ANZ J Surg 2004;74:573-6
   PubMed Web of Science ®Google Scholar
• Schmieder G, Stankov G, Zerle G, et al. Observer-blind study with metamizole versus tramadol and butylscopolamine in acute biliary colic pain. Arzneimittelforschung 1993;43:1216-21
   PubMed Web of Science ®Google Scholar
• Al-Waili N, Saloom KY. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. Eur J Med Res 1998;3:475-9
   PubMedGoogle Scholar
• Großkopf E. The alternative treatment of biliary colic. Z Allg Med 1988;64:723-6
   Google Scholar
• Malesci A, Pezzilli R, D’Amato M, et al. CCK-1 receptor blockade for treatment of biliary colic: a pilot study. Aliment Pharmacol Ther 2003;18:333-7
   PubMed Web of Science ®Google Scholar
• Lauretti GR, Lima IC. The effects of intrathecal neostigmine on somatic and visceral pain: improvement by association with a peripheral anticholinergic. Anesth Analg 1996;82:617-20
   PubMed Web of Science ®Google Scholar
• Habib A, Sharpe P, Anderson S, et al. Buscopan® for the treatment of pain after laparoscopic sterilisation. Anaesthesia 2001;56:174-6
   PubMed Web of Science ®Google Scholar
• Wilson CM, Lillywhite N, Matta B, et al. Intravenous Buscopan for analgesia following laparoscopic sterilisation. Anaesthesia 1999;54:389-92
   PubMed Web of Science ®Google Scholar
• Wixforth J, Grond S, Lehmann KA. Ketorolac and butylscopolamine in combination with alfentanil for renal lithotripsy. Schmerz. 1998;12:396-9
   PubMed Web of Science ®Google Scholar
• Fischer D, Krumme H. Comparison of effectiveness of 4-methylumbelliferone and hyoscine-N-butylbromide in therapy following biliary tract surgery. Med Welt. 1980;31:894-7
   PubMedGoogle Scholar
• Massoud TF, Nolan DJ. Dose reduction of hyoscine-N-butylbromide for double-contrast barium meal examinations – a prospective randomized study. Clin Radiol 1992;46:340-3
   PubMed Web of Science ®Google Scholar
• Goei R, Nix M, Kessels AH, et al. Use of antispasmodic drugs in double contrast barium enema examination: glucagon or Buscopan? Clin Radiol 1995;50:553-7
   Google Scholar
• Cittadini G, Sardanelli F, De Cicco E, et al. Compared effect of a genetically engineered glucagon and hyoscine-N-butylbromide on double-contrast barium meal study. Eur Radiol 1998;8:449-53
   PubMed Web of Science ®Google Scholar
• Braccini G, Marraccini P, Marrucci A, et al. Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide. Abdom Imaging 1994;19:201-6
   PubMed Web of Science ®Google Scholar
• Marraccini P, Braccini G, Marrucci A, et al. Pirenzepine versus scopolamine methyl bromide in double-contrast barium enema study of large bowel. Abdom Imaging 1996;21:304-8
   PubMed Web of Science ®Google Scholar
• Lee JR. Routine use of hyoscine-N-butylbromide (Buscopan) in double contrast barium enema examinations. Clin Radiol 1982;33:273-6
   PubMed Web of Science ®Google Scholar
• Elson EM, Campbell DM, Halligan S, et al. The effect of timing of intravenous muscle relaxant on the quality of double-contrast barium enema. Clin Radiol 2000;55:395-7
   PubMed Web of Science ®Google Scholar
• Ayre-Smith G. Hyoscine-N-butylbromide (Buscopan) as a duodenal relaxant in tubeless duodenography. Acta Radiol Diagn (Stockh) 1976;17:701-13
   PubMedGoogle Scholar
• Rajah RR. Effects of Buscopan on gastro-oesophageal reflux and hiatus hernia. Clin Radiol 1990;41:250-2
   PubMed Web of Science ®Google Scholar
• McLoughlin RF, Mathieson JR, Chipperfield PM, et al. Effect of hyoscine butylbromide on gastroesophageal reflux in barium studies of the upper gastrointestinal tract. Can Assoc Radiol J 1994;45:452-4
   PubMed Web of Science ®Google Scholar
• Chopra K, Westaby D, Murray-Lyon I. Why use Buscopan during diagnostic upper gastrointestinal endoscopy? Gut 1996;38:473
   Google Scholar
• Johnson W, Taylor MB, Carrington BM, et al. The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 2007;62:1087-93
   PubMed Web of Science ®Google Scholar
• Laniado M, Grönewäller E, Kopp AF, et al. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 1997;22:381-8
   PubMed Web of Science ®Google Scholar
• Dosdá R, Martí-Bonmatí L, Ronchera-Oms CL, et al. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 2003;13:294-8
   PubMed Web of Science ®Google Scholar
• Martí-Bonmatí L, Graells M, Ronchera-Oms CL. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 1996;21:309-13
   PubMed Web of Science ®Google Scholar
• Nasu K, Kuroki Y, Sekiguchi R, et al. Measurement of the apparent diffusion coefficient in the liver: is it a reliable index for hepatic disease diagnosis? Radiat Med 2006;24:438-44
   Google Scholar
• Rogalla P, Lembcke A, Rückert JC, et al. Spasmolysis at CT colonography: butyl scopolamine versus glucagon. Radiology 2005;236:184-8
   PubMed Web of Science ®Google Scholar
• Taylor SA, Halligan S, Goh V, et al. Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology 2003;229:99-108
   PubMed Web of Science ®Google Scholar
• Bruzzi JF, Moss AC, Brennan DD, et al. Efficacy of IV Buscopan as a muscle relaxant in CT colonography. Eur Radiol 2003;13:2264-70
   PubMed Web of Science ®Google Scholar
• Aschoff AJ, Görich J, Sokiranski R, et al. Pancreas: does hyoscyamine butylbromide increase the diagnostic value of helical CT? Radiology 1999;210:861-4
   Google Scholar
• Alper MM, Garner PR, Spence JE. Hyoscine butylbromide to relieve utero-tubal obstruction at hysterosalpingography. Br J Radiol 1985;58:915
   Web of Science ®Google Scholar
• Stahl A, Weber WA, Avril N, et al. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nucl Med (Stuttg) 2000;39:241-5
   Web of Science ®Google Scholar
• Emmott J, Sanghera B, Chambers J, et al. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun 2008;29:11-6
   PubMed Web of Science ®Google Scholar
• Kinnunen J, Saarinen O, Ahovuo J, et al. Urography with spasmolytics. Rontgenblatter 1990;43:20-3
   PubMedGoogle Scholar
• Kozak RI, Bennett JD, Brown TC, et al. Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 1994;45:209-11
   PubMed Web of Science ®Google Scholar
• Rowland-Hill CA, Loveday EJ, Thomas ML. A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction. Vasa 1989;18:301-3
   PubMedGoogle Scholar
• Bennett C, Phillips GW, Colthurst JR, et al. The value of hyoscine butylbromide in aorto-iliac intravenous digital subtraction angiography. Vasa 1987;16:262-4
   PubMedGoogle Scholar
• Saunders BP, Elsby B, Boswell AM, et al. Intravenous antispasmodic and patient-controlled analgesia are of benefit for screening flexible sigmoidoscopy. Gastrointest Endosc 1995;42:123-7
   PubMed Web of Science ®Google Scholar
• Saunders BP, Williams CB. Premedication with intravenous antispasmodic speeds colonoscope insertion. Gastrointest Endosc 1996;43:209-11
   PubMed Web of Science ®Google Scholar
• Misra SP, Dwivedi M. Role of intravenously administered hyoscine butyl bromide in retrograde terminal ileoscopy: a randomized, double–blinded, placebo-controlled trial. World J Gastroenterol 2007;13:1820-3
   PubMed Web of Science ®Google Scholar
• East JE, Saunders BP, Burling D, et al. Virtual colonoscopy to assess the quantitative effect of antispasmodic and position change on mucosal visualisation at optical colonoscopy. Endoscopy 2006;38(Suppl II):(Abstract A224)
   Google Scholar
• Ansari A, Soon SY, Saunders BP, et al. A prospective study of the technical feasibility of ileoscopy at colonoscopy. Scand J Gastroenterol 2003;38:1184-6
   PubMed Web of Science ®Google Scholar
• Han DS, Song SC, Park JY, et al. A clinical usefulness of premedication with hyoscine-N-butyl bromide (Buscopan®) in total colonoscopy. Gastroenterology 1997;112(Suppl):(Abstract A17)
   Google Scholar
• Yoong KY, Perkin D, Portal J, et al. Intravenous hyoscine as a premedication for colonoscopy: a randomized double-blind controlled trial. Endoscopy 2004;36:720-2
   PubMed Web of Science ®Google Scholar
• Netri G, Coco C, Aronne O, et al. Premedication for colonoscopy. Randomized double blind study of hyoscine-N-butyl bromide, pentazocine + atropina and a placebo. Acta Med Rom 1983;21:32-6
   Google Scholar
• Moral I, Vicente C, Castro J, et al. Does hyoscine butylbromide treatment mean any improvement to the conscious sedation on performing colonoscopy procedures? Endoscopy 2006;38(Suppl II):(Abstract A227)
   Google Scholar
• Mui LM, Ng EK, Chan KC, et al. Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine-N-butylbromide in patients undergoing colonoscopy with patient-controlled sedation. Gastrointest Endosc 2004;59:22-7
   PubMed Web of Science ®Google Scholar
• Hannigan BF, Axon AT, Avery S, et al. Buscopan or glucagon for endoscopic cannulation of ampulla of Vater? J R Soc Med 1982;75:21-2
   Google Scholar
• Chang FY, Guo WS, Liao TM, et al. A randomized study comparing glucagon and hyoscine-N-butylbromide before endoscopic retrograde cholangiopancreatography. Scand J Gastroenterol 1995;30:283-6
   PubMed Web of Science ®Google Scholar
• Yoshikawa I, Yamasaki M, Taguchi M, et al. Comparison of glucagon and scopolamine butylbromide as premedication for colonoscopy in unsedated patients. Dis Colon Rectum 2006;49:1393-8
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Adachi K, Ishimura N, et al. Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy – a comparative study with butyl scopolamine bromide. Aliment Pharmacol Ther 2002;16:111-8
   PubMed Web of Science ®Google Scholar
• Petrillo M, Lazzaroni M, Saponati G, et al. The use of rociverine as premedication for endoscopy of the upper gastro-intestinal tract: a double-blind controlled clinical trial. Curr Med Res Opin 1980;7:73-6
   PubMed Web of Science ®Google Scholar
• Hiki N, Kurosaka H, Tatsutomi Y, et al. Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial. Gastrointest Endosc 2003;57:475-82
   PubMed Web of Science ®Google Scholar
• Accinelli G, Olivieri T, Vibelli C. The effectiveness of a new spasmolytic drug (DA 3177) during the active phase of labor. A double-blind clinical trial. Acta Ther 1978;4:19-27
   Google Scholar
• Samuels LA, Christie L, Roberts-Gittens B, et al. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG 2007;114:1542-6
   PubMed Web of Science ®Google Scholar
• Klingberg MA, Abramovici A, Chemke J. Drugs and fetal development. Adv Exp Med Biol 1972;27:366-75
   Google Scholar
• Negro S, Reyes R, Azuara ML, et al. Morphine, haloperidol and hyoscine-N-butylbromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients. Int J Pharm 2006;307:278-84
   PubMedGoogle Scholar
• Barcia E, Martín A, Azuara ML, et al. Tramadol and hyoscine-N-butylbromide combined in infusion solutions: compatibility and stability. Support Care Cancer 2007;15:57-62
   PubMed Web of Science ®Google Scholar
• Hughes A, Wilcock A, Corcoran R, et al. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med 2000;14:221-2
   PubMed Web of Science ®Google Scholar
• Laval G, Arvieux C, Stefani L, et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 2006;31:502-12
   PubMed Web of Science ®Google Scholar
• De Conno F, Caraceni A, Zecca E, et al. Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 1991;6:484-6
   PubMed Web of Science ®Google Scholar
• Mercadante S. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction. J Pain Symptom Manage 1998;16:278-80
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Tsilika E, Kalaidopoulou O, et al. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Anticancer Res 2002;22:1187-92
   PubMed Web of Science ®Google Scholar
• Mercadante S, Ripamonti C, Casuccio A, et al. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000;8:188-91
   PubMed Web of Science ®Google Scholar
• Abel G, Erbslöh J, Thoma H. Methods and results of bladder-pressure determination. Z Geburtshilfe Gynakol 1971;175:153-62
   PubMedGoogle Scholar
• Wolters A, Sökeland J, Weil W, et al. Parasympathicolytic treatment of abnormal neurogenic bladder function: a urodynamic study. Dtsch Med Wochenschr 1980;105:1344-7
   PubMed Web of Science ®Google Scholar
• Bouin M, Lupien F, Riberdy-Poitras M, et al. Tolerance to gastric distension in patients with functional dyspepsia: modulation by a cholinergic and nitrergic method. Eur J Gastroenterol Hepatol 2006;18:63-8
   PubMed Web of Science ®Google Scholar
• Rauniyar RK, Agrawal CS, Baboo S, et al. Live ascariasis of gall bladder and bile duct: clinical and radiological features. Trop Doct 2004;34:46-8
   PubMed Web of Science ®Google Scholar
• Buscopan®. Summary of Product Characteristics. Data on file, Boehringer Ingelheim GmbH
   Google Scholar
• Mehlfeld G, Bleichert A. The effect of anticholinergic drugs on the inner eye muscles. Graefes Arch Clin Exp Ophthalmol 1986;224:92-5
   PubMed Web of Science ®Google Scholar
• Sissons GR, McQueenie A, Mantle M. The ocular effects of hyoscine-n-butylbromide (‘Buscopan’) in radiological practice. Br J Radiol 1991;64:584-6
   PubMed Web of Science ®Google Scholar
• Pfeiffer A, Kaess H, Bödeker RH, et al. Heart rate increase after intravenous administration of trospium chloride and scopolamine during endoscopic retrograde cholangiopancreatography. Endoscopy 1999;31:507
   PubMed Web of Science ®Google Scholar
• Barlow JD, Gregersen H, Thompson DG. Identification of the biomechanical factors associated with the perception of distension in the human esophagus. Am J Physiol Gastrointest Liver Physiol 2002;282:G683-G689
   Google Scholar
• Hosking SW, Robinson P, Johnson AG. Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices. Gut 1987;28:1151-6
   PubMedGoogle Scholar
• Gregersen H, Hausken T, Yang J, et al. Mechanosensory properties in the human gastric antrum evaluated using B-mode ultrasonography during volume-controlled antral distension. Am J Physiol Gastrointest Liver Physiol 2006;290:G876-G882
   PubMed Web of Science ®Google Scholar
• Conrad G, Schmidt R. Comparative investigation of buscolysin and cerucal in the stomach and duodenum. Zschr inn Med 1976;31:377-82
   Google Scholar
• Brandstätter G. Pharmacological pressure reduction in the human common bile duct. Z Gastroenterol 1983;21:168-74
   PubMed Web of Science ®Google Scholar
• Kewenter J, Kock NG. The effect of some spasmolytic drugs on the choledocho-duodenal junction in man. Scand J Gastroenterol 1971;6:401-5
   PubMed Web of Science ®Google Scholar
• Wu SD, Kong J, Wang W, et al. Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary Pancreat Dis Int 2003;2:121-5
   PubMedGoogle Scholar
• Allescher HD, Neuhaus H, Hagenmüller F, et al. Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP – a manometric study. Endoscopy 1990;22:160-3
   PubMed Web of Science ®Google Scholar
• Vertova F, Subelli M, Chierichetti S, et al. Comparison in man of the effects of a new parasympatholytic agent (DA 3177) on gall-bladder emptying. Curr Ther Res Clin Exp 1976;20:572-8
   Web of Science ®Google Scholar
• Zwergel UE, Zwergel TB, Neisius DA, et al. Effects of prostaglandin synthetase inhibitors on the upper urinary tract. Experimental studies on isolated preparations and urodynamic measurements in men. Urol Res 1990;18:429-33
   PubMed Web of Science ®Google Scholar
• Knipper W. The effect of Buscopan on renal pressure. Medizinische 1953;21:778-81
   PubMedGoogle Scholar
• Fink AM, Aylward GW. Buscopan and glaucoma: a survey of current practice. Clin Radiol 1995;50:160-4
   PubMed Web of Science ®Google Scholar